Mercados españoles cerrados

Boston Scientific Corporation (BSX)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
39,42+0,08 (+0,20%)
A partir del 2:59PM EDT. Mercado abierto.

Boston Scientific Corporation

300 Boston Scientific Way
Marlborough, MA 01752-1234
United States
508 683 4000
http://www.bostonscientific.com

Sector(es)Healthcare
SectorMedical Devices
Empleados a tiempo completo38.000

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Michael F. MahoneyChairman, Pres & CEO2,23MN/A1965
Mr. Daniel J. BrennanExec. VP & CFO1,04M708,41k1966
Mr. Edward F. MackeyExec. VP of Global Operations909,74kN/A1963
Mr. Joseph M. FitzgeraldExec. VP & Pres of Interventional Cardiology1,01M2,61M1964
Mr. Jeffrey B. MirvissExec. VP & Pres of Peripheral Interventions875,74k4,15M1966
Mr. Jonathan R. MonsonVP, Global Controller & Chief Accounting OfficerN/AN/AN/A
Ms. Jodi Euerle EddySr. VP and Chief Information & Digital OfficerN/AN/A1973
Ms. Susan Vissers LisaVP of Investor RelationsN/AN/AN/A
Ms. Catherine JenningsVP of Global Marketing & New Bus. Devel. of Peripheral InterventionsN/AN/AN/A
Ms. Wendy CarruthersSr. VP of HRN/AN/A1969
Los importes son a partir de 31 de diciembre de 2020 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

Gobierno corporativo

El ISS Governance QualityScore de Boston Scientific Corporation, a día 1 de abril de 2021, es 5. Las puntuaciones base son Auditoría: 7; Tablero: 8; Derechos de los accionistas: 7; Compensación: 1.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.